Mystic, CT, United States of America

Laura Turner

This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laura Turner. Retrieved from https://idiyas.com/inventor/laura-turner-grkoqb7g

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Laura Turner - Innovator in Antibiotic Development

Introduction

Laura Turner is a prominent inventor based in Mystic, Connecticut. She has made significant contributions to the field of antibiotic research, particularly with her work on novel thiazolyl peptide antibiotic compounds.

Latest Patents

Laura Turner holds one patent for her invention titled "Nocathiacin antibiotics." This patent discloses novel thiazolyl peptide antibiotic compounds, including nocathiacin I, II, and III. Additionally, it introduces a novel microorganism, ATCC-202099, which plays a crucial role in her research.

Career Highlights

Laura is currently employed at Bristol-Myers Squibb Company, where she continues to advance her research in antibiotic development. Her work has the potential to impact the treatment of bacterial infections significantly.

Collaborations

Some of her notable coworkers include John E. Leet and Helen A. Ax, who have collaborated with her on various projects within the company.

Conclusion

Laura Turner's innovative work in antibiotic development exemplifies the importance of research in combating bacterial infections. Her contributions are paving the way for new treatments and advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…